Janssen posts Phase 3 ExPEC9V vaccine results; registers new guselkumab IBD studySep 30Weekly roundup, 2 itemsguselkumabJohnson & JohnsonUpdated
J&J raises 2026 sales and EPS guidance after strong Q2 resultsJul 15Quarterly updateJohnson & Johnson
Sign inSign in